SCHEMBL30746381

SCHEMBL30746381

CNS(=O)(=O)Nc1nccc(Cc2cncc(Nc3ccc(Cl)cc3F)c2C)c1OC

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NUDT1 P36639 4/20 0.38
▸ FLT1 P17948 8/20 0.37
▸ KDR P35968 8/20 0.37
▸ FGFR1 P11362 6/20 0.37
▸ RAF1 P04049 4/20 0.35
▸ MAP2K1 Q02750 4/20 0.35
▸ EGFR P00533 3/20 0.35
▸ FLT4 P35916 3/20 0.35
▸ EPHB2 P29323 1/20 0.35
▸ TGFBR1 P36897 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ BRAF P15056 1/20 0.34
▸ MAP2K2 P36507 1/20 0.34
▸ MAP2K5 Q13163 1/20 0.34
▸ SLC40A1 Q9NP59 1/20 0.34
▸ CSF1R P07333 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26984976 1.00 NUDT1 (0.38) NUDT1FLT1KDRFGFR1RAF1
SCHEMBL26984961 0.90 RAF1 (0.42) NUDT1FLT1KDRFGFR1RAF1
SCHEMBL30746529 0.90 RAF1 (0.42) NUDT1FLT1KDRFGFR1RAF1
SCHEMBL26985123 0.87 RAF1 (0.39) NUDT1FLT1KDRFGFR1RAF1
SCHEMBL30746644 0.87 RAF1 (0.39) NUDT1FLT1KDRFGFR1RAF1
SCHEMBL30746356 0.85 SLC6A2 (0.38) RAF1MAP2K1CYP2C9BRAFMAP2K2
SCHEMBL26984865 0.85 SLC6A2 (0.38) RAF1MAP2K1CYP2C9BRAFMAP2K2
SCHEMBL26985334 0.85 RAF1 (0.41) FLT1KDRFGFR1RAF1MAP2K1
SCHEMBL30746407 0.83 KDR (0.41) NUDT1FLT1KDRFGFR1EGFR
SCHEMBL30746378 0.83 KDR (0.41) NUDT1FLT1KDRFGFR1EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120129678-A Mitogen-activated protein kinase (MEK) inhibitors 耐斯泰德医疗公司 2025-06-10 — — CN disclosed
EP-4551558-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS Nested Therapeutics, Inc. (US) 2025-05-14 — — EP disclosed
WO-2024010925-A2 MITOGEN-ACTIVATED PROTEIN KINASE (MEK) INHIBITORS NESTED THERAPEUTICS, INC. (US) 2024-01-11 — — WO disclosed
Send feedback